StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.49−0.12 (-3.31%)

Close on Nov 18, 2026Market cap $190.84MP/E –Yield –

Intercure pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Intercure's pe ratio was 35.2× on Feb 29, 2024, against 410.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Feb 29, 202435.2×+11.7
2023Dec 29, 202323.6×−504.6
2022Dec 30, 2022528.1×–

More Intercure figures

See a number that looks wrong?